Trial intelligence / Profile preview

Phase II randomized trial of Icatibant in hospitalized COVID-19 pneumonia patients without assisted ventilation

2020-002166-13Phase 2Completed

Sponsor: Dr. RamÃ³n Lleonart Bellfill / Dr. Xavier Corbella VirÃ³s
Start: Jul 2020
Modality: Peptides
Countries: 1

Overview

Phase 2, randomised, open-label trial of icatibant in coronavirus pneumonia and coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Dr. RamÃ³n Lleonart Bellfill / Dr. Xavier Corbella VirÃ³s. Started Jul 2020; status: completed.

Drugs

icatibant

Conditions

coronavirus pneumoniacoronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on 2020-002166-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-002166-13.